Kuros Biosciences Reports First Half of 2025 Results

(SWX:KURN), Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences Reports First Half of 2025 Results Financial Highlights Total Medical Device sales rose by 78% to USD 63.5 million in H1 2025 (H1 2024: USD 35.7 million) Direct MagnetOs(TM) sales increased by 77% to USD 62.7 million in H1 2025 (H1 […]

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

(Paris:SAN), Sanofi's rilzabrutinib earns orphan designation in the EU for IgG4-related disease Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025 Additional orphan designation underscores Sanofi commitment to advancing new medicines in immune-mediated rare diseases Paris, August 14, 2025. The European Medicines Agency has granted

Zealand Pharma Announces Financial Results for the First Half of 2025

Zealand Pharma Announces Financial Results for the First Half of 2025 GlobeNewswire August 14, 2025 Company announcement – No. 18 / 2025 Zealand Pharma Announces Financial Results for the First Half of 2025Petrelintide collaboration with Roche off to a strong start, while key leadership appointments and solid financial position enable exciting next chapter for Zealand

Kuros Biosciences Reports First Half of 2025 Results

Kuros Biosciences Reports First Half of 2025 Results GlobeNewswire August 14, 2025 Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences Reports First Half of 2025 Results Financial Highlights Total Medical Device sales rose by 78% to USD 63.5 million in H1 2025 (H1 2024: USD 35.7 million) Direct MagnetOs(TM) sales

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

Press Release: Sanofi's rilzabrutinib earns orphan designation in the EU for IgG4-related disease GlobeNewswire August 14, 2025 Sanofi's rilzabrutinib earns orphan designation in the EU for IgG4-related disease Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025 Additional orphan designation underscores Sanofi commitment to advancing

BRI Launches Taipei Branch to Provide Financial Services for 360,000 Indonesian Migrant Workers in Taiwan

PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI)has expanded into Taiwan and East Asia with the launch of BRI Taipei Branch, located at No. 166, Sec. 3, Nanjing East Road, Zhongshan District, Taipei City. https://mma.prnewswire.com/media/2750404/WhatsApp_Image_2025_08_14_at_11_33_40_AM.jpg At the Grand Launching Ceremony on Friday, August 8, 2025, Hery Gunardi, BRI's President Director, highlighted, “As the only Indonesian

Parents Urged to Make Kids’ Bedtime Screen-Free as National Campaign Launches with NYC Flash Mob

“Screen-Free Sleep” movement takes to the streets to address America's youth sleep crisis In a bold wake-up call to parents everywhere, the team behind the acclaimed Screenagers documentaries and the “Away for the Day” campaign launched its latest national initiative on Tuesday, August 12th in NYC: Screen-Free Sleep, a movement to keep kids' bedrooms device-free

Zeekr Group Reports Second Quarter 2025 Unaudited Financial Results

ZEEKR Intelligent Technology Holding Limited (“Zeekr Group” or the “Company”) (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its unaudited financial results for the second quarter ended June 30, 2025.[1] Operating Highlights for the Second Quarter of 2025 — Total vehicle deliveries were 130,866 units for the second quarter of 2025,

SM Investments H1 net income rises 6% to PHP42.6 billion

SM Investments Corporation (SM Investments) posted a consolidated net income of PHP42.6 billion in the first half of 2025, a 6% increase from PHP40.2 billion in the same period last year. https://mma.prnewswire.com/media/1880730/Logo.jpg Consolidated revenues for the January to June period rose 6% to PHP319.2 billion, up from PHP301.4 billion in the first half of 2024.

Re-opening of Food Expo and concurrent fairs

Following the lifting of the Black Rainstorm Warning Signal at 11:10am, the Food Expo, Beauty & Wellness Expo, Home Delights Expo, Food Expo PRO and Hong Kong International Tea Fair will reopen at 1:10pm. The Food Expo, Beauty & Wellness Expo, Home Delights Expo will be extended and close at 11pm from 15 August to

Scroll to Top